LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Risk Factors Identified for Little-Known Lung Infections

By LabMedica International staff writers
Posted on 25 Mar 2014
Image: Colonies of the nontuberculous Mycobacteria cosmeticum growing on Middlebrook 7H10 agar (Photo courtesy of James Gathany).
Image: Colonies of the nontuberculous Mycobacteria cosmeticum growing on Middlebrook 7H10 agar (Photo courtesy of James Gathany).
Severe and sometimes fatal lung disease caused by a group of bacteria in the same family as those that cause tuberculosis is much more common than previously thought.

Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria found in water and soil that can infect the lungs when inhaled, but unlike tuberculosis, NTM is not contagious and cannot spread from person to person.

Scientists at the University of Illinois (Chicago, IL, USA) analyzed mortality related to nontuberculous mycobacterial infections from 1999 through 2010 by examining multiple-cause-of-death data from the National Center for Health Statistics (Atlanta, GA, USA). They analyzed age-adjusted mortality rates, trends, associations with demographic variables, and comorbid conditions and correlated this information with similar data for tuberculosis-related mortality during the same time.

The investigators found that NTM was listed as immediate cause of death for 2,990 people, of whom 87% were 55 or older, 85% were white, and 52% were female. NTM-related deaths also correlated with smoking, cancer, human immunodeficiency virus (HIV) infection, and chronic obstructive pulmonary disease. They also found that the age-adjusted NTM mortality rates were uneven across the USA. Tuberculosis-related deaths among ethnic groups were also disproportional as among those with tuberculosis, 4,847 (59%) were white.

The team suggested that both warm and dry climates may contribute to NTM disease and influence on mortality by different environmental factors, such as temperature, soil and water conditions. NTM demonstrated a strong relationship with some comorbid conditions such as chronic obstructive pulmonary disease, chronic respiratory failure, bronchiectasis, HIV, interstitial lung diseases, rheumatoid arthritis, hematopoietic malignancies and tobacco use. The infection is treatable, but antibiotic therapy is expensive and can take up to two years. Examples of nontuberculous mycobacteria that should be distinguished from tubercle bacilli are Mycobacterium chelonae, M. abscessus, M. fortuitum, and M. cosmeticum

Mehdi Mirsaeidi, MD, MPH, the lead author said, “People and physicians need to be aware of NTM, especially as we see more of it, and because it can look like a lot of other pulmonary diseases. Patients usually present with a cough, and correct diagnosis can take years. Having a better understanding of the risk factors associated with NTM will give us a better chance of diagnosing it faster. This is important, because it's largely a curable infection.” The study was published on March 14, 2014, in the journal Public Library of Science ONE.

Related Links:

University of Illinois
National Center for Health Statistics


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more